Literature DB >> 24724735

Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.

Peter Y Chang1,2, Zvi Kresch1,2, C Michael Samson1,2, Ronald C Gentile1,2,3.   

Abstract

PURPOSE: To report two cases of spontaneous Retisert implant dissociation with dislocation of the medication reservoir into the anterior chamber. DESIGN AND METHODS: Case reports.
RESULTS: Two patients with chronic, noninfectious uveitis following Retisert implantation between 6 and 7 years prior presented with a complaint of a "white spot" in their right eyes. Both patients had previous pars plana vitrectomies. Anterior segment examination revealed a dislocated medication reservoir of the Retisert implant in the inferior portion of anterior chamber with associated reservoir-corneal endothelial touch and stromal edema. The reservoirs were subsequently retrieved via a pars plana approach and removed from the anterior chamber through a corneal incision.
CONCLUSIONS: Spontaneous dissociation of the Retisert implant with dislocation of the medication reservoir into the anterior chamber can be a late complication of Retisert implantation. Eye care professionals and patients should be aware of this complication, particularly with long-term intraocular retention of this device.

Entities:  

Keywords:  Anterior chamber; Retisert; dislocation; dissociation; fluocinolone acetonide; implant; separation; spontaneous; uveitis

Mesh:

Substances:

Year:  2015        PMID: 24724735     DOI: 10.3109/09273948.2014.902074

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design.

Authors:  Onyinye J Uwaezuoke; Pradeep Kumar; Viness Pillay; Yahya E Choonara
Journal:  Drug Deliv Transl Res       Date:  2021-01-16       Impact factor: 4.617

2.  Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema.

Authors:  Lea F Weber; Stefanie Marx; Gerd U Auffarth; Alexander F Scheuerle; Tamer Tandogan; Christian Mayer; Ramin Khoramnia
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-01-29

3.  Dexamethasone Implant Migration through an Iris Coloboma.

Authors:  Yoav Glidai; Shulamit Schwartz; Eyal Cohen
Journal:  Case Rep Ophthalmol       Date:  2020-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.